Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.
CAS Number:
[1417158-65-6]
Target:
IGF-1R|||Akt
* VAT and and shipping costs not included. Errors and price changes excepted